Wednesday, August 30, 2017 10:15 PM ET
Insider Makes Sale of Alexion Pharmaceuticals (ALXN) Shares Slowing 90 Day Buying Trend
One Alexion Pharmaceuticals insider Julie O’Neill, Officer, today, disposed of 11,160 shares having a market value of approximately $1,562,400, as disclosed in a form 4 document filed with the SEC. There have been 5 insiders with buy/sell transactions in the past 90 days prior to this filing. These trades have resulted in the acquisition of 1,360,955 company shares and the sale of 1,535 company shares over this time period. Adding the most recent activity to this 90-day history indicates insider trades have been net purchases of 1,348,260 shares and have averaged 228,942 shares per transaction over this time period.
Compared to its peers over the last 90 days, insider buy/sell trading at Alexion Pharmaceuticals is higher than the 42-company peer group average. Biopharmaceuticals peer group saw 29 buy/sell trades during this period for an average of 0.7 transactions per company. The number of shares per buy/sell trade for Alexion Pharmaceuticals insiders was also higher. Within the peer group there were 1,380,455 shares purchased and 1,953,394 shares sold with company insiders selling 19,757 shares on average.
In determining significant insider buying and selling, trades reported to the SEC that involve awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers have been eliminated in data used to create and write this story.
Using proprietary artificial intelligence methods, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at email@example.com. Copyright 2017 UpTick Data Technologies. All rights reserved.